Volumetric response of intracranial meningioma after photon or particle irradiation

References

• Marosi C, Hassler M, Roessler K, et al. Meningioma. Crit Rev Oncol Hematol. 2008;67:153–171.
   PubMed Web of Science ®Google Scholar
• Bondy M, Ligon BL. Epidemiology and etiology of intracranial meningiomas: a review. J Neurooncol. 1996;29:197–205.
   PubMed Web of Science ®Google Scholar
• Beks JWF, Dewindt HL. The recurrence of supratentorial meningiomas after surgery. Acta Neurochir. 1988;95:3–5.
   PubMed Web of Science ®Google Scholar
• Demonte F, Smith HK. Outcome of aggressive removal of cavernous sinus meningiomas. J Neurosurg. 1994;81:245–251.
   PubMed Web of Science ®Google Scholar
• Walcott BP, Nahed BV, Brastianos PK, et al. Radiation treatment for WHO grade II and III meningiomas. Front Oncol. 2013;3:227.
   PubMedGoogle Scholar
• Adeberg S, Hartmann C, Welzel T, et al. Long-term outcome after radiotherapy in patients with atypical and malignant meningiomas-clinical results in 85 patients treated in a single institution leading to optimized guidelines for early radiation therapy. Int J Radiat Oncol Biol Phys. 2012;83:859–864.
   PubMed Web of Science ®Google Scholar
• Debus J, Wuendrich M, Pirzkall A, et al. High efficacy of fractionated stereotactic radiotherapy of large base-of-skull meningiomas: long-term results. J Clin Oncol. 2001;19:3547–3553.
   PubMed Web of Science ®Google Scholar
• Milker-Zabel S, Zabel-Du Bois A, Huber P, et al. Fractionated stereotactic radiation therapy in the management of benign cavernous sinus meningiomas: long-term experience and review of the literature. Strahlenther Onkol. 2006;182:635–640.
   PubMed Web of Science ®Google Scholar
• Combs SE, Adeberg S, Dittmar JO, et al. Skull base meningiomas: long-term results and patient self-reported outcome in 507 patients treated with fractionated stereotactic radiotherapy (FSRT) or intensity modulated radiotherapy (IMRT). Radiother Oncol. 2013;106:186–191.
   PubMed Web of Science ®Google Scholar
• Compter I, Zaugg K, Houben RMA, et al. High symptom improvement and local tumor control using stereotactic radiotherapy when given early after diagnosis of meningioma A multicentre study. Strahlenther Onkol. 2012;188:887–893.
   PubMed Web of Science ®Google Scholar
• Combs SE, Bohl J, Elsasser T, et al. Radiobiological evaluation and correlation with the local effect model (LEM) of carbon ion radiation therapy and temozolomide in glioblastoma cell lines. Int J Radiat Biol. 2009;85:126–137.
   PubMed Web of Science ®Google Scholar
• Milker-Zabel S, Zabel A, Schulz-Ertner D, et al. Fractionated stereotactic radiotherapy in patients with benign or atypical intracranial meningioma: long-term experience and prognostic factors. Int J Radiat Oncol Biol Phys. 2005;61:809–816.
   PubMed Web of Science ®Google Scholar
• Combs SE, Welzel T, Habermehl D, et al. Prospective evaluation of early treatment outcome in patients with meningiomas treated with particle therapy based on target volume definition with MRI and 68Ga-DOTATOC-PET. Acta Oncol. 2013;52:514–520.
   PubMed Web of Science ®Google Scholar
• Combs SE, Kalbe A, Nikoghosyan A, et al. Carbon ion radiotherapy performed as re-irradiation using active beam delivery in patients with tumors of the brain, skull base and sacral region. Radiother Oncol. 2011;98:63–67.
   PubMed Web of Science ®Google Scholar
• Combs SE, Edler L, Burkholder I, et al. Treatment of patients with atypical meningiomas Simpson grade 4 and 5 with a carbon ion boost in combination with postoperative photon radiotherapy: the MARCIE Trial. BMC Cancer. 2010;10:8.
   PubMed Web of Science ®Google Scholar
• Astner ST, Theodorou M, Dobrei-Ciuchendea M, et al. Tumor shrinkage assessed by volumetric mri in the long-term follow-up after stereotactic radiotherapy of meningiomas. Strahlenther Onkol. 2010;186:423–429.
   PubMed Web of Science ®Google Scholar
• Henzel M, Gross MW, Hamm K, et al. Significant tumor volume reduction of meningiomas after stereotactic radiotherapy: results of a prospective multicenter study. Neurosurgery. 2006;59:1188–1194.
   PubMed Web of Science ®Google Scholar
• Kessel KA, Bohn C, Engelmann U, et al. Five-year experience with setup and implementation of an integrated database system for clinical documentation and research. Comput Methods Programs Biomed. 2014;114:206–217.
   PubMed Web of Science ®Google Scholar
• Gehler B, Paulsen F, Oksuz MO, et al. Ga-68 -DOTATOC-PET/CT for meningioma IMRT treatment planning. Radiat Oncol. 2009;4:8.
   PubMed Web of Science ®Google Scholar
• Milker-Zabel S, Zabel-Du Bois A, Henze M, et al. Improved target volume definition for fractionated stereotactic radiotherapy in patients with intracranial meningiomas by correlation of CT, MRI, and Ga-68 – DOTATOC-PET. Int J Radiat Oncol Biol Phys. 2006;65:222–227.
   PubMed Web of Science ®Google Scholar
• Thorwarth D, Henke G, Muller AC, et al. Simultaneous (68)Ga-DOTATOC-PET/MRI for IMRT treatment planning for meningeoma: first experience. Int J Radiat Oncol Biol Phys. 2011;81:277–283.
   PubMed Web of Science ®Google Scholar
• Combs SE, Hartmann C, Nikoghosyan A, et al. Carbon ion radiation therapy for high-risk meningiomas. Radiother Oncol. 2010;95:54–59.
   PubMed Web of Science ®Google Scholar
• Park HJ, Kang HC, Kim IH, et al. The role of adjuvant radiotherapy in atypical meningioma. J Neurooncol. 2013;115:241–247.
   PubMed Web of Science ®Google Scholar
• Maclean J, Fersht N, Short S. Controversies in radiotherapy for meningioma. Clin Oncol (R Coll Radiol). 2014;26:51–64.
   PubMed Web of Science ®Google Scholar
• Combs SE, Laperriere N, Brada M. Clinical controversies: proton radiation therapy for brain and skull base tumors. Semin Radiat Oncol. 2013;23:120–126.
   PubMed Web of Science ®Google Scholar